KRAS blockers

KRAS blockers

featured image of Jazz Pharma Pays $10 Million for Cancer Treatment Breakthrough

Jazz Pharma Pays $10 Million for Cancer Treatment Breakthrough

BIOT

🎯 Jazz Pharmaceuticals secures KRAS blockers from Redx Pharma 💰 $10M upfront, up to $870M milestones 💊 Enhancing cancer treatment options.